Summit Therapeutics Inc. - COM (SMMT)

Historical Portfolio Holders from Q3 2020 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
72.2M
Holdings value Q2 2024
$563M
Value change Q2 2024
+$186M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
116
Number of buys Q2 2024
53
Number of sells Q2 2024
-67
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 121K $2.64M +$1.24M $21.89 2
2024 Q2 72.2M $563M +$186M $7.80 121
2024 Q1 49.6M $206M +$72.5M $4.14 101
2023 Q4 32.3M $84.4M +$2.19M $2.61 93
2023 Q3 32.3M $60.4M -$5.14M $1.87 90
2023 Q2 34.9M $87.6M +$36.4M $2.51 96
2023 Q1 21.1M $37M +$21.8M $1.75 86
2022 Q4 8.1M $34.5M +$22.6M $4.25 58
2022 Q3 3.17M $3.77M -$5.11M $1.19 38
2022 Q2 8.46M $8.46M -$4.23M $1.00 33
2022 Q1 10.9M $26.8M -$300K $2.45 45
2021 Q4 11M $29.7M +$54.2K $2.69 49
2021 Q3 10.9M $54.8M -$944K $5.01 51
2021 Q2 11M $82.4M +$14.1M $7.46 53
2021 Q1 9.28M $54.5M +$1.36M $5.87 36
2020 Q4 9.06M $42.6M +$2.51M $4.70 31
2020 Q3 7.75M $26.8M +$26.8M $3.44 15